20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity

Vandana Singh

October 31, 2025

Benzinga

DexCom posts Q3 revenue of $1.21 billion, beating estimates and raising 2025 guidance as analysts expect strong sales and margin improvement ahead.

Latest Ratings for DXCM

Date	Firm	Action	From	To
Feb 2022	Morgan Stanley	Maintains		Equal-Weight
Feb 2022	BTIG	Upgrades	Neutral	Buy
Jan 2022	Wells Fargo	Upgrades	Equal-Weight	Overweight

View More Analyst Ratings for DXCM

View the Latest Analyst Ratings

Market Impact

12 Communication Services Stocks Moving In Friday's Pre-Market Session

November 7, 2025

Benzinga

Market Impact

12 Health Care Stocks Moving In Friday's Pre-Market Session

November 7, 2025

Benzinga

Market Impact

12 Industrials Stocks Moving In Friday's Pre-Market Session

November 7, 2025

Benzinga

Market Impact

Tuya Accelerates AI Strategy

September 5, 2025

Benzinga

Market Impact

BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data

September 5, 2025

Benzinga

Market Impact

This Twilio Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

September 5, 2025

Benzinga

Equities

HOOD Bets on Football Prediction Markets: Can it Score Long-Term Gains?

August 20, 2025

Barchart

Markets

Lithium Market Soars as CATL Shuts One of World’s Top Mines

August 11, 2025

Bloomberg

Equities

Chart of the Day 9/3/25: Should You Worry About THIS September?

September 3, 2025

Barchart

Enjoy premium content in your inbox.

You're in! Check your email to learn more.

Oops! Something went wrong while submitting the form.

20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity

Latest Ratings for DXCM

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

News

Tools

More

Follow